Yukio Horikawa Selected Research

Type 6 MODY

1/2019

Genetic Dissection and Clinical Features of MODY6 (NEUROD1-MODY).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yukio Horikawa Research Topics

Disease

22	Type 2 Diabetes Mellitus (MODY) 04/2022 - 04/2002
9	Insulin Resistance 05/2021 - 01/2002
4	Diabetes Mellitus 01/2016 - 05/2003
3	Hyperglycemia 04/2022 - 06/2011
3	Glucose Intolerance 05/2021 - 02/2009
2	Graves Disease (Basedow Disease) 09/2022 - 01/2022
2	Type 2 Maturity-Onset Diabetes of the Young 04/2022 - 01/2020
2	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 06/2016
2	Neoplasms (Cancer) 01/2021 - 03/2016
2	Body Weight (Weight, Body) 03/2018 - 01/2014
2	Fatty Liver 03/2018 - 06/2015
2	Renal Insufficiency (Renal Failure) 01/2016 - 10/2008
2	Hypertension (High Blood Pressure) 08/2009 - 08/2008
2	Mason-Type Diabetes 12/2008 - 11/2003
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2008 - 08/2008
1	Thymus Hyperplasia 09/2022
1	Primary Hyperparathyroidism 06/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	COVID-19 01/2022
1	Compression Fractures (Compression Fracture) 01/2022
1	Coma (Comas) 01/2022
1	Hypertriglyceridemia 05/2021
1	Hyperplasia 01/2021
1	Starvation 01/2021
1	Carcinoma (Carcinomatosis) 09/2020
1	Periodontal Diseases (Periodontal Disease) 04/2020
1	Hyperuricemia 12/2019
1	Renal cysts and diabetes syndrome 12/2019
1	Type 6 MODY 01/2019
1	Infections 11/2018
1	Dyslipidemias (Dyslipidemia) 03/2018
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 02/2018
1	Hyperphagia (Overeating) 02/2018
1	Vomiting 02/2017
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 02/2017
1	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 02/2017
1	Fever (Fevers) 02/2017

Drug/Important Bio-Agent (IBA)

15	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 01/2002
7	Insulin (Novolin)FDA Link 10/2021 - 01/2002
4	Pharmaceutical PreparationsIBA 04/2022 - 02/2008
4	Messenger RNA (mRNA)IBA 11/2018 - 10/2005
4	Transcription Factors (Transcription Factor)IBA 08/2008 - 05/2003
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2021 - 03/2016
3	Cysteine Proteases (Cysteine Protease)IBA 01/2005 - 04/2002
2	GlucokinaseIBA 04/2022 - 01/2020
2	Peptides (Polypeptides)IBA 10/2021 - 08/2009
2	Triglycerides (Triacylglycerol)IBA 05/2021 - 02/2009
2	Hormones (Hormone)IBA 01/2021 - 01/2014
2	C-PeptideIBA 01/2020 - 12/2002
2	Hepatocyte Nuclear Factor 1-betaIBA 12/2019 - 11/2003
2	EnzymesIBA 12/2019 - 02/2009
2	CalpainIBA 11/2018 - 05/2003
2	Adenosine Triphosphate (ATP)IBA 02/2017 - 08/2006
2	Dipeptidyl-Peptidase IV InhibitorsIBA 06/2016 - 06/2011
2	Biomarkers (Surrogate Marker)IBA 03/2016 - 01/2016
2	CarbohydratesIBA 06/2015 - 08/2008
2	IncretinsIBA 01/2014 - 05/2011
2	Metformin (Glucophage)FDA LinkGeneric 01/2012 - 02/2008
2	Proteins (Proteins, Gene)FDA Link 05/2011 - 05/2007
2	Hepatocyte Nuclear FactorsIBA 12/2008 - 11/2003
2	calpain 10IBA 02/2005 - 07/2002
2	DNA (Deoxyribonucleic Acid)IBA 04/2002 - 01/2002
1	Methimazole (Thiamazole)FDA LinkGeneric 09/2022
1	Long-Acting Thyroid Stimulator (LATS)IBA 09/2022
1	Calcium-Sensing ReceptorsIBA 06/2022
1	VaccinesIBA 01/2022
1	VildagliptinIBA 01/2022
1	glimepiride (Amarel)FDA LinkGeneric 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	HLA-A Antigens (HLA-A)IBA 01/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2021
1	AutoantibodiesIBA 10/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 05/2021
1	HDL LipoproteinsIBA 05/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	oil red OIBA 01/2021
1	CorticosteroneIBA 01/2021
1	Cosyntropin (Cortrosyn)FDA LinkGeneric 01/2021
1	Arginine (L-Arginine)FDA Link 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 11/2018
1	fibroblast growth factor 21IBA 11/2018
1	Biological ProductsIBA 07/2018
1	Amino Acids FDA Link 07/2018
1	Sucrose (Saccharose)IBA 03/2018
1	VLDL LipoproteinsIBA 03/2018
1	SodiumIBA 02/2018
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 02/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2017
1	Adrenocorticotropic Hormone (ACTH)FDA Link 02/2017
1	BiguanidesIBA 06/2016
1	Hemoglobins (Hemoglobin)IBA 03/2016

Therapy/Procedure

3	Glycemic Control 01/2019 - 01/2012
2	Therapeutics 04/2020 - 06/2011
2	Aftercare (After-Treatment) 02/2008 - 05/2007
1	Activities of Daily Living (ADL) 01/2022
1	Radiotherapy 01/2021
1	Cystectomy 09/2020
1	Nephrectomy 09/2020
1	Duration of Therapy 04/2020
1	Diet Therapy (Therapy, Diet) 02/2018